Acyclovir Suspension and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Acyclovir Suspension and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acyclovir
Brand name: Sitavig, Zovirax
Synonyms: Acyclovir, Acyclovir (Systemic)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acyclovir Suspension-Insulin degludec
- Acyclovir Suspension-Insulin Degludec (U-100) Prefilled Pens
- Acyclovir Suspension-Insulin Degludec (U-100) Vials
- Acyclovir Suspension-Insulin Degludec (U-200) Prefilled Pens
- Acyclovir Suspension-Insulin degludec and liraglutide
- Acyclovir Suspension-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Acyclovir Tablets
- Insulin aspart, recombinant Subcutaneous-Acyclovir topical
- Insulin aspart, recombinant Subcutaneous-Acys-5
- Insulin aspart, recombinant Subcutaneous-Aczone
- Insulin aspart, recombinant Subcutaneous-Aczone Topical
- Insulin aspart, recombinant Subcutaneous-Adacel